STOCK TITAN

Main Results of 2025 Annual and Extraordinary General Meeting

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Alvotech (ALVO) held its 2025 Annual and Extraordinary General Meeting on June 25, 2025 in Luxembourg. The company announced that all proposed resolutions on the meeting agenda were successfully approved by shareholders. The official notarized meeting minutes and detailed voting results will be made available on the company's investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+3.18%
1 alert
+3.18% News Effect

On the day this news was published, ALVO gained 3.18%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, Grand Duchy of Luxembourg. 

All of the draft resolutions on the 2025 AGM agenda were approved. Notarized meeting minutes and voting results will be published on the Company’s special web portal for the 2025 Annual General Meeting at:

https://investors.alvotech.com/corporate-governance/annual-general-meeting-2025

Alvotech Investor Relations
Benedikt Stefansson
alvotech.ir@alvotech.com


FAQ

When and where was Alvotech's (ALVO) 2025 Annual General Meeting held?

Alvotech's 2025 Annual General Meeting was held on June 25, 2025 at Arendt House, 41A Avenue John F. Kennedy in Luxembourg.

What were the results of Alvotech's (ALVO) 2025 AGM?

All draft resolutions presented on the 2025 AGM agenda were approved by shareholders.

Where can investors find the detailed voting results of Alvotech's 2025 AGM?

The notarized meeting minutes and voting results will be available on Alvotech's investor portal at investors.alvotech.com under the Corporate Governance section.

Who should investors contact for more information about Alvotech's 2025 AGM?

Investors can contact Benedikt Stefansson from Alvotech Investor Relations at alvotech.ir@alvotech.com.
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Latest SEC Filings

ALVO Stock Data

1.61B
117.87M
61.79%
6.49%
0.47%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg City